Jim Cullen
Cullen Value Fund
Cullen Value Fund 13F holdings
Jim Cullen's Portfolio
- Portfolio value:
- $26.90M≈
- # of securities:
- 39
- Reported for:
- 30 Sep 2021 (Q3)
- Latest filing date:
- 19 Nov 2021
What was Jim Cullen's 2021 Q3 portfolio?
Cullen Value Fund has disclosed a total of 39 security holdings in their (2021 Q3) SEC filing(s) with portfolio value of $26,895,618.
Cullen Value Fund's portfolio holdings are tracked quarterly based on SEC filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Jim Cullen's original SEC reports (2021 Q3) are the official SEC institutional disclosure documents covering all reported equity positions.
39 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Morgan Stanley
|
4.48%
|
12,370
|
$97.31
|
+115.60%($209.80)
|
$1,203,725
|
2019 Q3
|
≈ 2.25 years
|
Common Stock
|
|
|
|
|
|
JPMorgan Chase & Co
|
4.19%
|
6,884
|
$163.69
|
+115.08%($352.07)
|
$1,126,842
|
2019 Q3
|
≈ 2.25 years
|
Common Stock
|
|
|
|
|
|
Thermo Fisher Scientific Inc
|
3.79%
|
1,786
|
$571.33
|
+0.66%($575.08)
|
$1,020,395
|
2019 Q3
|
≈ 2.25 years
|
Common Stock
|
|
|
|
|
|
Siemens AG ADR
|
3.76%
|
12,326
|
$82.14
|
+99.98%($164.26)
|
$1,012,458
|
2019 Q3
|
≈ 2.25 years
|
Depositary Receipt
|
|
|
|
|
|
Chubb Ltd
|
3.69%
|
5,723
|
$173.48
|
+100.11%($347.14)
|
$992,826
|
2019 Q3
|
≈ 2.25 years
|
Common Stock
|
|
|
|
|
|
Pfizer Inc
|
3.53%
|
22,072
|
$43.01
|
-42.01%($24.94)
|
$949,317
|
2019 Q3
|
≈ 2.25 years
|
Common Stock
|
|
|
|
|
|
Citigroup Inc
|
3.31%
|
12,680
|
$70.18
|
+88.24%($132.11)
|
$889,882
|
2019 Q3
|
≈ 2.25 years
|
Common Stock
|
|
|
|
|
|
The Allstate Corp
|
3.29%
|
6,950
|
$127.31
|
+106.53%($262.93)
|
$884,804
|
2019 Q3
|
≈ 2.25 years
|
Common Stock
|
|
|
|
|
|
Medtronic PLC
|
3.26%
|
7,005
|
$125.35
|
-31.19%($86.25)
|
$878,077
|
2019 Q3
|
≈ 2.25 years
|
Common Stock
|
|
|
|
|
|
Bristol-Myers Squibb Company
|
3.17%
|
14,420
|
$59.17
|
+9.62%($64.86)
|
$853,231
|
2019 Q3
|
≈ 2.25 years
|
Common Stock
|
|
|
|
Completely sold out
2 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
Newmont Goldcorp Corp
|
-11,770
|
-2.89%
|
2019 Q3
|
≈ 2.00 years
|
|
|
|
Communication Services Select Sector SPDR Fund
|
-6,270
|
-1.96%
|
2021 Q2
|
≈ 0.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.